2006 Archive

December 7, 2006
New Billing Code and Medicare payment Recommendation Issued for Lp-PLA2 Testing

November 14, 2006
Studies Presented at AHA Confirm Role of Inflammatory Marker Lp-PLA2 in Assessing Cardiovascular Risk and in Secondary Prevention

November 8, 2006
diaDexus Reports Study Showing Lp-PLA2 Is an Independent Marker of Coronary Artery Disease and Death

November 1, 2006
Study Suggests Lp-PLA2 Plays a Causal Role in Plaque Instability and Subsequent Sudden Coronary Death

October 31, 2006
diaDexus to Present at Rodman & Renshaw 8th Annual Healthcare Conference

October 24, 2006
Study Shows Inflammatory Enzyme Lp-PLA2 Predicts Recurrent Stroke

October 16, 2006
diaDexus to Present at BIO InvestorForum 2006

October 9, 2006
Extended Release Niacin Reduces Cardiovascular Inflammatory Marker LP-PLA2

August 1, 2006
Panel Recommends Values for LP-PLA2 in the Assessment of Cardiovascular Disease Risk

June 26, 2006
New Data Published in an American Heart Association Journal Shows that Lipoprotein-Associated Phospholipase A2 Independently Adds to the Diagnostic Accuracy of Traditional Risk Assessment for Future Cardiovascular Events

May 30, 2006
diaDexus announces issued U.S. patent for Lp-PLA2 Activity-Based Atherosclerosis Diagnostic Test

March 30, 2006
CFD Therapeutics Formed To Advance Novel Monoclonal Antibodies For Cancer

March 28, 2006
diaDexus to Present at 'Future Leaders in the Biotech Industry' Conference March 30

March 14, 2006
Studies Presented at ACC Annual Meeting Further Validate the PLAC® Test, the Test for Lp-PLA2, a Cardiovascular-Specific Biomarker

February 16, 2006
Simple Blood Test Shown to Help Predict Risk of Recurrent Stroke in African Americans, Hispanics and Women

January 18, 2006
New Study Shows That Elevated Lp-PLA2 Signals Early Endothelial Dysfunction, A Marker Of Atherosclerosis, In Humans